Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceHeart & metabolic

Policosanol

Policosanol is a textbook case of results that only appear in one country. Cuban trials reported statin-sized cholesterol reductions; every well-conducted independent trial outside Cuba found essentially nothing.

What the science says

  • Lowers LDL cholesterol Limited evidence

    Dozens of Cuban trials, largely from a single research group with commercial ties to the manufacturer, reported LDL reductions of 20-30%. The definitive independent test — a German randomised, double-blind, placebo-controlled trial in 143 patients using 10, 20, 40 and 80 mg/day of Cuban sugarcane policosanol for 12 weeks — found no significant change in LDL, HDL, triglycerides or Lp(a) at any dose. Later independent trials in Germany, the US and South Africa have consistently agreed with the null result.

  • Lowers blood pressure Limited evidence

    A 2019 meta-analysis of randomised trials reported small reductions in systolic and diastolic blood pressure, but the pooled studies are heavily weighted toward the same source region as the lipid literature, and heterogeneity is substantial. This should not be taken as independent confirmation of a real effect.

  • Raises HDL cholesterol Limited evidence

    HDL increases of 8-15% appear in the Cuban literature but were absent in the independent placebo-controlled trials that measured them. There is no convincing mechanism and no replication.

Dosage & safety

Studied doseStudies used 5-40 mg/day of sugarcane-derived policosanol (roughly 60% octacosanol), usually as a single evening dose for 8-24 weeks. Note that most commercial products in Western markets are derived from wheat germ, rice bran or beeswax rather than the Cuban sugarcane preparation used in trials — and even the Cuban material failed independent testing. Given the evidence, there is no dose that can be recommended with confidence.
SafetyPolicosanol is remarkably well tolerated in trials — adverse events matched placebo, and meta-analyses of liver enzymes and creatinine found no signal of harm. The real risk is not toxicity but opportunity cost: someone with high cardiovascular risk who uses policosanol instead of a proven lipid-lowering therapy loses years of treatment benefit. Because policosanol may mildly inhibit platelet aggregation, use caution alongside aspirin, clopidogrel or anticoagulants. Insufficient data in pregnancy and breastfeeding.

Scientific references

Where to buy

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic